Merck & Co Inc (NYSE:MRK)
$ 130.06 -0.17 (-0.13%) Market Cap: 329.42 Bil Enterprise Value: 358.02 Bil PE Ratio: 144.51 PB Ratio: 8.16 GF Score: 88/100

Merck & Co Inc ESG Investor Event Transcript

Feb 23, 2022 / 03:00PM GMT
Release Date Price: $75.84 (-0.14%)
Peter Dannenbaum
Merck & Co., Inc. - VP of IR

Good morning, afternoon or evening, everyone. Welcome to Merck's Inaugural ESG Investor Event. We're excited to speak to you today about how we are building on Merck's 130-year legacy of operating responsibly with our approach to environmental, social and governance management and our related commitments, initiatives and impact.

For today's event, our President and Chief Executive Officer, Rob Davis, will lead off with an introduction to Merck's mission, vision and values. Caroline Litchfield, Executive Vice President and Chief Financial Officer, will then discuss how we deliver long-term business value through ESG. Julie Gerberding, Chief Patient Officer and Executive Vice President, Population Health and Sustainability, will share our ESG approach and strategy. Following Julie, we will take a closer look at the issues we are addressing and the impact we are having within each of our 4 ESG pillars.

Louise Houson, Senior Vice President, Global Market Access; and Eliav Barr, Senior Vice President, Global Medical Affairs, will discuss

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot